Journals / Forbes tıp dergisi (Online) / 2022 / Cilt: 3 - Sayı: 1

Prenatal and Postnatal Consequences of Drug Exposure inPregnancy

Gebelikte İlaç Maruziyetinin Prenatal ve Postnatal Sonuçları

Pages
75–82
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that drugs related to the nervous system were used most frequently with a rate of 29.33%, followed by drugs related to the digestive system with a rate of 15.03%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the demographic characteristics of pregnant women that have a history of drug use and categorize the drugs according to the Anatomic Therapeutic Chemical Classification (ATC) system.
📊
Key Findings & Data:Mean age of pregnant women was 31.7 [18-47, standard deviation (SD)=5.880], mean gravida was 2.81 (1-8, SD=1.452), mean parity was 1.4 (0-5, SD=0.988) and mean gestational week at presentation was 11.27 (5-30, SD=4.692).
💡
Conclusion & Impact:It was found that drugs related to the nervous system were used most frequently with a rate of 29.33%, followed by drugs related to the digestive system with a rate of 15.03%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the demographic characteristics of pregnant women that have a history of drug use and categorize the drugs according to the Anatomic Therapeutic Chemical Classification (ATC) system. Methods: This study was designed as a retrospective cohort study. The data obtained from the hospital database were evaluated. The drugs used by pregnant women who were found to use drugs during pregnancy were categorized according to the ATC system. At the same time, demographic data, educational status, income levels, alcohol and cigarette use and obstetric results of the pregnant women were evaluated. Results: Ninety-nine pregnant women evaluated in Tepecik Training and Research Hospital Perinatology Department Council were included. Mean age of pregnant women was 31.7 [18-47, standard deviation (SD)=5.880], mean gravida was 2.81 (1-8, SD=1.452), mean parity was 1.4 (0-5, SD=0.988) and mean gestational week at presentation was 11.27 (5-30, SD=4.692). It was determined that the mean duration of drug use was 66.56 days. It was found that drugs related to the nervous system were used most frequently with a rate of 29.33%, followed by drugs related to the digestive system with a rate of 15.03%. Congenital anomalies were observed in only 5 of 100 pregnant women exposed to the drug. Conclusion: The demographic data of pregnant women and the distribution of the drugs they are exposed to are similar to the literature. However, unlike previous studies, the preference for optional curettage is lower and the incidence of congenital anomaly is not higher than expected.

Özet

Amaç: Hastanemize başvuran ve perinatoloji konseyimizde değerlendirdiğimiz gebelerden ilaç kullanım öyküsü olanların demografik özelliklerini ve maruz kalınan ilaçların Yapısal Tedavi Edici Kimyasallar Sınıflaması (ATC) sistemine göre dağılımlarını belirlemektir. Yöntem: Bu araştırma retrospektif kohort bir çalışma olarak tasarlanmıştır. Hastane veri tabanından elde edilen veriler, literatür ışığında değerlendirilmiştir. Gebeliğinde ilaç kullanımı tespit edilen gebelerin sıklıkla hangi ilaçları kullandıkları ATC sistemine göre kategorize edildi. Aynı zamanda gebelerin demografik verileri, eğitim durumları, gelir seviyeleri, alkol sigara kullanımları, obstetrik sonuçları incelendi. Bulgular: Çalışmamıza İzmir Tepecik Eğitim ve Araştırma Hastanesi, Perinatoloji Bölümü Konseyi’nde değerlendirilen 99 gebe dahil edildi. Gebelerde ortalama yaş 31,70 [18-47, standart sapma (SS)=5,880], ortalama gravida 2,81 (1-8, SS=1,452), ortalama parite 1,4 (0-5, SS=0,988) ve başvuru sırasındaki ortalama gebelik haftası 11,27 (5-30, SS=4,692) olarak hesaplandı. Ortalama ilaç kullanım süresinin ortalama 66,56 gün olduğu tespit edildi. Çalışmamızda %29,33 oranıyla en sık sinir sistemini ilgilendirilen ilaçların kullanıldığı bunu %15,03 oranıyla sindirim sistemini ilgilendiren ilaçların takip ettiği gözlendi. İlaca maruz kalan 100 gebenin sadece 5’inde doğumsal anomali gözlemlenmiştir. Sonuç: Gebelerin demografik verileri, maruz kaldıkları ilaçların dağılımları literatür ile benzer şekildedir. Ancak daha önceki çalışmalardan farklı olarak isteğe bağlı küretaj tercihi daha düşük orandadır. Bununla birlikte doğumsal anomali görülme durumu da beklenenden yüksek değildir.

🔖

Cite This Article

KARACA, S. Y., UÇAR, E., GÖLBAŞI, C., GÖLBAŞI, H., DEMİR, Ö., ÖMEROĞLU, İ., EKİN, A., SEVER, B., ÖZER, M., ÇAKIR, Z. E. (2022). Prenatal and Postnatal Consequences of Drug Exposure inPregnancy. Forbes tıp dergisi (Online), Cilt: 3 - Sayı: 1, 75–82. https://ajindex.com/articles/517886

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Headley J, Northstone K, Simmons H, Golding J; ALSPAC Study Team. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol. 2004;60:355-61
  2. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S; National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;205:51. e1-8
  3. Kaplan YC CH, Demir Ö, Karadaş B, Yılmaz İ, Temiz TK. A new era begins in risk communication regarding drug use in pregnancy: Changes in fda pregnancy risk categories. Turkish Journal of Family Practice 2014;18:195-8
  4. Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4:e004365
  5. Ayad M, Costantine MM. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39:508-11
  6. Who Collaborating Centre for Drug Statistics Methodology. Last Accessed Date: 09.02.2022. Available from: https://www. Whocc.No/atc_ddd_methodology/purpose_of_the_atc_ddd_ system/. 11 242021 7. Koyuncu Arslan M, Akar M, Pala HG, Taner CE, Oncel MY. Evaluation of fetal central nervous system anomalies; perinatology council data of a reference center. Forbes J Med. 2020;1:75-8
  7. Sayan A, Karaçay Ş, Okay T, Arıkan A. Perinatoloji konsey sonuçları: 6 yıllık verilerin değerlendirilmesi. Çocuk Cerrahisi Dergisi. 2007;21:68-73
  8. Statistics kingdom. Son Erişim Tarihi: 09.02.2022. Erişim Adresi:
  9. Demir Ö, Arıcı MA, Demiral Y, Tuncok Y. Evaluation of drugs exposure in pregnancy according to different risk categories: Do fda-based decisions lead to more curettage? Turkiye Klinikleri J Med Sci. 2012;32:901-9
  10. Türkiye cumhuriyeti sağlık bakanlığı sağlık bilgi sistemleri genel müdürlüğü. Sağlık İstatistikleri yıllığı 2019. 2021
  11. Türkiye İstatistik kurumu. Son Erişim Tarihi: 09.03.2022. Erişim Adresi:
  12. Hibbard BM, Hibbard ED, Jeffcoate TN. Folic acid and reproduction. Acta Obstet Gynecol Scand. 1965;44:375-400
  13. De Santis M, Quattrocchi T, Mappa I, et al. Folic acid use in planned pregnancy: an Italian survey. Matern Child Health J. 2013;17:661-6
  14. Köken GN, Derbent AU, Erol O, Saygın N, Ayık H, Karaca M. Awareness and use of folic acid among reproductive age and pregnant women. J Turk Ger Gynecol Assoc. 2013;14:87-91
  15. Yurtsever C, Se